Skip to Main Content
Table 1

Clinicopathological parameters(n = 51)

CharacteristicsNo. of patients%
Sex   
Male 39 76 
Female 12 24 
Age (y)   
Median 67  
Range 26–91  
T stage   
Ta 13 25 
T1 21 41 
T2 18 
T3a 
T3b 
T4 
Grade of tumor   
G1 
G2 35 69 
G3 13 25 
Clinical status   
Untreated primary tumor 23 45 
Recurrent tumor after TUR-Bta and intravesical chemotherapyb 16 31 
Residual tumor after systemic chemotherapyc 12 24 
CharacteristicsNo. of patients%
Sex   
Male 39 76 
Female 12 24 
Age (y)   
Median 67  
Range 26–91  
T stage   
Ta 13 25 
T1 21 41 
T2 18 
T3a 
T3b 
T4 
Grade of tumor   
G1 
G2 35 69 
G3 13 25 
Clinical status   
Untreated primary tumor 23 45 
Recurrent tumor after TUR-Bta and intravesical chemotherapyb 16 31 
Residual tumor after systemic chemotherapyc 12 24 
a

TUR-Bt, transurethral resection of bladder tumor.

b

Intravesical chemotherapy is prophylactic intravesical instillation chemotherapy with doxorubicin or its derivatives.

c

Systemic chemotherapy is methotrexate, vincristine, adriamycin, and cisplatin combined chemotherapy.

Close Modal

or Create an Account

Close Modal
Close Modal